Register to receive a free US Market for In-Vitro Diagnostics Report Suite – 2016 report synopsis and brochure
Typenex Medical, an industry leader in medical devices and supplies, recently announced it is bringing Rad-Control, a new irradiation indicator tag technology, to blood banks and blood centers in the United States and Canada. Typenex Medical has exclusively partnered with a European market leader, On Point Indicators GmbH, to offer the product to its customers. The product technology confirms blood irradiation by visual verification, minimizes current documentation practices and increases efficiency for healthcare staff.
“The irradiation indicator tag market has not seen innovation within the last decade. We are excited to launch Rad-Control, and breathe some life into this market,” said John Fife, owner, and chief executive officer (CEO), Typenex Medical. “With increasing pressures on healthcare facilities to do more with less, we are positioned to help improve workflows while providing compelling value.”
Rad-Control is used in hospitals and blood centers to ensure the blood component has been exposed to irradiation. The specially-formulated indicator technology in the tag changes color after exposure, acting as a visual verification. This practice has been common in ensuring blood components are irradiated, confirming that components have received irradiation, and helping to prevent multiple irradiation cycles. Properly irradiating blood helps to prevent life threatening Transfusion-Associated Graft-vs.-Host Disease (TA-GvHD).
Read more at the press release here: https://globenewswire.com/news-release/2017/09/06/1108438/0/en/Typenex-Medical-Brings-Innovative-Blood-Irradiation-Indicator-to-Market.html
For Further Information
More on the in vitro market in the U.S. can be found in the report series published by iData entitled US Market for In-Vitro Diagnostics Report Suite – 2016. This report covers the U.S. market segments for the Immunochemistry Market, Molecular Diagnostics Market, Molecular Blood Donor Screening Market, Hemostasis Market, Hematology Market, and Point of Care Diagnostic Device Market.
Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. Register online or email us at [email protected] for a US Market for In-Vitro Diagnostics Report Suite – 2016 report brochure and synopsis.